Shuchang Liu

Title: Shuchang Liu: Innovator in Prostate Cancer Research

Introduction

Shuchang Liu is a notable inventor based in Pittsburgh, PA, who has made significant contributions to the field of cancer research. His work primarily focuses on developing methods to predict prostate cancer relapse, which is crucial for improving patient outcomes.

Latest Patents

Liu holds a patent titled "Methods for predicting prostate cancer relapse." This invention relates to methods for determining whether a subject with prostate cancer is at an increased risk for relapse or rapid relapse. The patent is based on a comprehensive genome analysis of 273 prostate cancer samples, indicating that the percentage of large size copy number variations (CNVs) can predict prostate cancer relapse. In certain embodiments, the method involves determining the number and size of CNVs in a sample and calculating a large size ratio. If this ratio exceeds a specific threshold, the patient is considered at an increased risk for relapse or rapid relapse.

Career Highlights

Shuchang Liu is affiliated with the University of Pittsburgh, where he conducts his research and develops innovative solutions for cancer prediction and treatment. His work has the potential to significantly impact the way prostate cancer is managed and treated.

Collaborations

Liu collaborates with esteemed colleagues such as Jianhua Luo and Yanping Yu, contributing to a rich environment of research and innovation in the field of cancer studies.

Conclusion

Shuchang Liu's innovative methods for predicting prostate cancer relapse represent a significant advancement in cancer research. His contributions are vital for enhancing patient care and improving treatment strategies for prostate cancer.